Home News

First half 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.

Mon, 27/07/2020 - 00:00 0 min
Download related document
No votes yet
 
Related
ROVI announces an agreement with Biogaran for the marketing of its enoxaparin...
0 min
20/09/2018
ROVI has commenced the marketing of its enoxaparin biosimilar in Spain
0 min
19/09/2018
Press release - Grant for research project
Awarded a partially refundable grant for research project: Bluespe
1 min
31/07/2018